Literature DB >> 15025935

Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart.

Edith Hochhauser1, Oleg Kaminski, Hemdat Shalom, Dorit Leshem, Vladimir Shneyvays, Asher Shainberg, Bernardo A Vidne.   

Abstract

The aim of the present study was to investigate the protective role of pharmacological preconditioning on antioxidant enzymes using A(1) and A(3) adenosine receptor agonists in the recovery of the isolated myocardium after cardioplegic ischemia. Two different modes of preconditioning were studied: isolated rat hearts were perfused with A(1) receptor agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) or A(3) 2-chloro-N(6)-(3-iodobenzyl) adenosine-5'-N-methyluronamide (Cl-IB-MECA) (1 nM), followed by cardioplegic ischemia and reperfusion (30 min each) (perfusion mode), or CCPA or Cl-IB-MECA (100 micro g/kg) were injected intravenously 24 h before the experiment (injection mode). Hearts treated with CCPA improved in terms of mechanical function, infarct size, ATP levels, superoxide dismutase, and catalase (p < 0.005) in both modes of administration. Cl-IB-MECA was beneficial mainly in the injected group. Reduced damage to the mitochondria in the CCPA-treated hearts was observed using electron microscopy evaluation. In the Cl-IB-MECA-injected hearts, mitochondrial damage was moderate. CCPA in both modes of treatment and Cl-IB-MECA in the injected mode were beneficial in protecting the perfused isolated rat heart, subjected to normothermic cardioplegic ischemia. This protection was partially related to the higher myocardial activity of superoxide dismutase and catalase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025935     DOI: 10.1089/152308604322899404

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  5 in total

1.  Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart.

Authors:  T S Lancaster; S J Jefferson; D H Korzick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

2.  Adenosine A(1) and A (3) receptor agonists reduce hypoxic injury through the involvement of P38 MAPK.

Authors:  D Leshem-Lev; E Hochhauser; B Chanyshev; A Isak; A Shainberg
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

3.  Anti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.

Authors:  Bella Chanyshev; Asher Shainberg; Ahuva Isak; Alexandra Litinsky; Yelena Chepurko; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Edith Hochhauser; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2011-12-01       Impact factor: 7.658

4.  Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue.

Authors:  Paloma B Liton; Coralia Luna; Pratap Challa; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2006-07-12       Impact factor: 2.367

Review 5.  Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection.

Authors:  Lovedeep Singh; Ritu Kulshrestha; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.